Cargando…
Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655692/ https://www.ncbi.nlm.nih.gov/pubmed/38025538 http://dx.doi.org/10.1515/med-2023-0853 |
_version_ | 1785136872459075584 |
---|---|
author | Hegazy, Sahar K. Tharwat, Samar Hassan, Ahmed H. |
author_facet | Hegazy, Sahar K. Tharwat, Samar Hassan, Ahmed H. |
author_sort | Hegazy, Sahar K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10655692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-106556922023-11-10 Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients” Hegazy, Sahar K. Tharwat, Samar Hassan, Ahmed H. Open Med (Wars) Retraction De Gruyter 2023-11-10 /pmc/articles/PMC10655692/ /pubmed/38025538 http://dx.doi.org/10.1515/med-2023-0853 Text en © 2023 the author(s), published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. |
spellingShingle | Retraction Hegazy, Sahar K. Tharwat, Samar Hassan, Ahmed H. Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients” |
title | Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients” |
title_full | Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients” |
title_fullStr | Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients” |
title_full_unstemmed | Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients” |
title_short | Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients” |
title_sort | retraction to “study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized covid-19 patients” |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655692/ https://www.ncbi.nlm.nih.gov/pubmed/38025538 http://dx.doi.org/10.1515/med-2023-0853 |
work_keys_str_mv | AT hegazysahark retractiontostudytocomparetheeffectofcasirivimabandimdevimabremdesivirandfavipiravironprogressionandmultiorganfunctionofhospitalizedcovid19patients AT tharwatsamar retractiontostudytocomparetheeffectofcasirivimabandimdevimabremdesivirandfavipiravironprogressionandmultiorganfunctionofhospitalizedcovid19patients AT hassanahmedh retractiontostudytocomparetheeffectofcasirivimabandimdevimabremdesivirandfavipiravironprogressionandmultiorganfunctionofhospitalizedcovid19patients |